Clinical trial

Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute…

NCT00411541 · International BFM Study Group, Other · Completed

Key facts

NCT number NCT00411541
Title Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia
Official title Pulses of Vincristine and Dexamethasone During Maintenance in BFM Protocols for Children With Intermediate-Risk Acute Lymphoblastic Leukemia
Lead sponsor International BFM Study Group, Other
Collaborators Associazione Italiana Ematologia Oncologia Pediatrica BFM-A, Austria BFM-G, Germany and Switzerland CPH, Czech republic European Organisation for Research and Treatment of Cancer - EORTC Group for…
Status Completed
Phase Phase 4
Study type Interventional
Conditions Acute Lymphoblastic Leukemia
Intervention type Drug
Interventions vincristine, dexamethasone
Enrollment 2,600
Start date Apr 1, 1995
Completion Jan 1, 2004
First posted Dec 14, 2006
Last update posted Dec 14, 2006
Countries Argentina, Austria, Belgium, Chile, Czechia, Germany, Hungary, Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies